Chinese english Germany Japanese Korea

3-Isoquinolinecarboxamide, 2-(ethylsulfonyl)-N-(4-fluorophenyl)-1,2,3,4-tetrahydro-

3-Isoquinolinecarboxamide, 2-(ethylsulfonyl)-N-(4-fluorophenyl)-1,2,3,4-tetrahydro- Struktur
1008280-11-2
CAS-Nr.
1008280-11-2
Englisch Name:
3-Isoquinolinecarboxamide, 2-(ethylsulfonyl)-N-(4-fluorophenyl)-1,2,3,4-tetrahydro-
Synonyma:
WAY-325090;2-(Ethylsulfonyl)-N-(4-fluorophenyl)-1,2,3,4-tetrahydroisoquinoline-3-carboxamide;3-Isoquinolinecarboxamide, 2-(ethylsulfonyl)-N-(4-fluorophenyl)-1,2,3,4-tetrahydro-
CBNumber:
CB711312908
Summenformel:
C18H19FN2O3S
Molgewicht:
362.42
MOL-Datei:
1008280-11-2.mol
Request For Quotation

3-Isoquinolinecarboxamide, 2-(ethylsulfonyl)-N-(4-fluorophenyl)-1,2,3,4-tetrahydro- Eigenschaften

Dichte
1.36±0.1 g/cm3(Predicted)
pka
12.88±0.70(Predicted)

Sicherheit

3-Isoquinolinecarboxamide, 2-(ethylsulfonyl)-N-(4-fluorophenyl)-1,2,3,4-tetrahydro- Chemische Eigenschaften,Einsatz,Produktion Methoden

3-Isoquinolinecarboxamide, 2-(ethylsulfonyl)-N-(4-fluorophenyl)-1,2,3,4-tetrahydro- Upstream-Materialien And Downstream Produkte

Upstream-Materialien

Downstream Produkte

3-Isoquinolinecarboxamide, 2-(ethylsulfonyl)-N-(4-fluorophenyl)-1,2,3,4-tetrahydro- Anbieter Lieferant Produzent Hersteller Vertrieb Händler.

Global( 5)Lieferanten
Firmenname Telefon E-Mail Land Produktkatalog Edge Rate
Aladdin Scientific 		+1-+1(833)-552-7181
sales@aladdinsci.com United States 57511 58
MQ (shanghai) Pharmaceuticals Co., Ltd. 13761635123
 1014988033@qq.com China 4930 55
Bide Pharmatech Ltd. 400-1647117 13681763483
 product02@bidepharm.com China 62163 58
Xi'an Kaixin Biotechnology Co., Ltd 029-68881181 13619217766
 3495811982@qq.com China 2765 58
Shanghai Aladdin Biochemical Technology Co.,Ltd. +86-18521732826
 market@aladdin-e.com China 48465 58
  • 3-Isoquinolinecarboxamide, 2-(ethylsulfonyl)-N-(4-fluorophenyl)-1,2,3,4-tetrahydro-
  • 2-(Ethylsulfonyl)-N-(4-fluorophenyl)-1,2,3,4-tetrahydroisoquinoline-3-carboxamide
  • WAY-325090
  • 1008280-11-2
Copyright 2019 © ChemicalBook. All rights reserved